Page last updated: 2024-08-17

carbostyril and Hypophosphatemia

carbostyril has been researched along with Hypophosphatemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aghajanian, C; Caird, I; Grisham, RN; Guillen, J; Hensley, ML; Hyman, DM; Iasonos, A; Makker, V; O'Cearbhaill, RE; Rubinstein, MM; Sabbatini, P; Seier, K; Selcuklu, SD; Soldan, K; Tew, WP; Torrisi, J; Troso-Sandoval, T; Won, H; Zimel, C1

Trials

1 trial(s) available for carbostyril and Hypophosphatemia

ArticleYear
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
    Cancer, 2020, 03-15, Volume: 126, Issue:6

    Topics: Aged; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Endometrial Neoplasms; Enzyme Activation; Female; Humans; Hyperglycemia; Hypoalbuminemia; Hypophosphatemia; Middle Aged; Mutation; Phosphatidylinositol 3-Kinases; Progression-Free Survival; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Quinolones; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome

2020